Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 1, 2007, Pages 73-78

  Barreiro De Acosta, Manuel ^a   Enrique Dominguez Munoz J ^a,b   Concepcion Nunez Pardo De Vera M ^a   Lozano León, Antonio ^a   Lorenzo, Aurelio ^a   Peña, Salvador ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Crohn's disease; Extraintestinal manifestations; NOD2 CARD15; Risk factors; Vienna Classification

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; CHOLELITHIASIS; CLINICAL FEATURE; CONFIDENCE INTERVAL; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG DEPENDENCE; DRUG RESPONSE; ERYTHEMA NODOSUM; EYE DISEASE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; SACROILIITIS; SMOKING HABIT; STOMATITIS; THROMBOEMBOLISM;

ADULT; AGED; ARTHRITIS; CHOLELITHIASIS; COLITIS; CROHN DISEASE; ERYTHEMA NODOSUM; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; RISK FACTORS; SEX FACTORS;

EID: 33846039749     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000243883.47938.aa     Document Type: Article

References (32)

1. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31:307-327.
2. Hodgson HJF. Extraintestinal manifestations of inflammatory bowel disease. In: Jarnerot G, Lennard-Jones J, Truelove S, editors. Inflammatory bowel disease. Malmo: Corona AB and Astra; 1992. pp. 515-536.
3. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15.
4. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35:360-362.
5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeats variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
6. Nunez C, Barreiro M, Dominguez-Munoz JE, Lorenzo A, Zapata C, Pena AS. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population. Am J Gastroenterol 2004; 99:450-456.
7. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998; 42:387-391.
8. Huang C, Liechtnstein DR. Pancreatic and biliary tract disorders in inflammatory bowel disease. Gastrointest Endosc Clin North Am 2002; 12:535-559.
9. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National cooperative Crohn's disease study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77:914-920.
10. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96:1116-1122.
11. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55:401-412.
12. Pierer M, Krause C, Hantzschel H. Extra-intestinal manifestations of chronic inflammatory bowel diseases. Z Gastroenterol 2002; 40 (Suppl 1):S92.
13. Christodoulou DK, Katsanos KH, Kitsanou M, Stergiopoulou C, Hatzis J, Tsianos EV. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Digest Liver Dis 2002; 34:781-786.
14. Gheorghe C, Pascu O, Gheorghe L, Iacob R, Dumitru E, Tantau M, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol 2004; 16:1153-1159.
15. Zankel E, Rogler G, Andus T, Reng CM, Scholmerich J, Timmer A. Crohn's disease patients' characteristics in a tertiary referral center: comparison with patients from a population based cohort. Eur J Gastroenterol Hepatol 2005; 17:395-401.
16. Crespo M, Perez JR, Perez A, Miyar A. The extraintestinal manifestations of Crohn's disease: our experience. Rev Esp Enferm Dig 1991; 80:169-172.
17. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23:29-34.
18. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large North American cohort. Am J Gastroenterol 2006; 101:1012-1023.
19. White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, et al. Different patterns of inflammatory bowel disease between African-American children and other racial/ethnic groups in a large, multicentre registry of 1640 children. Gastroenterology 2004; 126:A457 [abstract].
20. Merrill PT, Kim J, Cox TA, Betor CC, McCallum RM, Jaffe GJ. Uveitis in the southeastern United States. Curr Eye Res 1997; 16:865-874.
21. Shikama Y, Kobayashi K, Kasahara K, Kaga S, Hashimoto M, Yoneya I, et al. Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granulomas formation. Am J Pathol 1989; 134:1189-1199.
22. Kasahara K, Kobayashi K, Shikama Y, Yoneya I, Kaga S, Hashimoto M, et al. The role of monokines in granulomas formation in mice: the ability of interleukin 1 and tumor necrosis factor-alpha to induce lung granulomas. Clin Immunol Immunopathol 1989; 51:419-425.
23. Rybicki BA, Major M, Popovich J Jr, Maliarick MJ, Iannuzzi MG. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241.
24. Wagtmans MJ, Verspaget HW, Lamers HW, van Hogezand RA. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol 2001; 96:1541-1546.
25. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003; 9:2300-2307.
26. Lakatos PL, Szalay F, Tulassay Z, Molnar T, Kovacs A, Gasztonyi B, et al. Clinical presentation of Crohn's disease. Association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepatogastroenterology 2005; 52:817-822.
27. Manguso F, Sanges M, Staiano T, Gargiulo S, Nastro P, Gargano D, et al. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 2004; 99:327-334.
28. Nemetz A, Molnar T, Zagoni T, Kovacs A, Tulassay Z, Nagy F, et al. Phenotypes defined by the 'Vienna Classification' in 100 Hungarian patients with Crohn's disease. Rev Esp Enferm Dig 2003; 95:527-538.
29. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70:845-857. Epub 2002 Mar 01.
30. Karban A, Waterman M, Panhuysen CI, Pollak RD, Nesher S, Datta L, et al. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am J Gastroenterol 2004; 99:1134-1140.
31. Lakatos L, Lakatos PL, Willheim-Polli C, Reinisch W, Ferenci P, Tulassay Z, et al. NOD2/CARD15 mutations in Hungarian patients with Crohn's disease. Association with disease phenotype and extraintestinal manifestations. Orv Hetil 2004; 145:1403-1411.
32. Peeters H, Vander Cruyssen B, Laukens D, Coucke P, Marichal D, Van den Berghe M, et al. Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease. Ann Rheum Dis 2004; 63:1131-1134.